MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    The initial motor symptom of Parkinson’s disease in relation to age at onset and gender: A Sri Lankan perspective

    V. Suriyakumara, R. Gamage, H. Gunasekara, T. Fernando, A. Jayasuriya, R. Wijeyekoon, T. Muthukuda, R. De Silva (Nugegoda, Sri Lanka)

    Objective: To investigate whether the predominant initial PD motor symptom is associated with gender or age of onset of PD in Sri Lanka. Background: Studies…
  • 2016 International Congress

    Medication errors: The role of the nurse in an interdisciplinary home visit program for advanced Parkinson’s disease patients

    S.E. Oyler, J.E. Fleisher, M.M. Sweeney, A.C. Lemen, A. Fazl, G. Dacpano, R.M. Gilbert, A. Di Rocco, J. Chodosh (New York, NY, USA)

    Objective: To examine the number and types of medication errors detected by a registered nurse during interdisciplinary home visits for patients with advanced Parkinson's disease…
  • 2016 International Congress

    Impact of subclinical apathy prior to deep brain stimulation on the quality of life of patients with Parkinson’s disease

    M.A. Higuchi, T. Mishima, H. Abe, T. Morishita, S. Fujioka, J. Fukae, Y. Tsuboi (Fukuoka, Japan)

    Objective: To evaluate the influence of pretreatment subclinical apathy on patient QOL following subthalamic nucleus DBS (STN-DBS) in PD patients 12 months after surgery. Background:…
  • 2016 International Congress

    Treating Parkinson’s 2015–A nationwide survey of treatment responses and complications in 1000 Irish patients with Parkinson’s disease

    C. Stubbe, P. Bogdanova-Mihaylova, N. Kavanagh, K. Mulpeter, D. Bradley, T. Lynch, T. Counihan, P. Brown, S. O'Sullivan, R.A. Walsh (Dublin, Ireland)

    Objective: To collect real-life data from a large cohort with Parkinson's disease (PD), with particular emphasis on drug regimens, motor complications, and quality of life…
  • 2016 International Congress

    Measuring interdependence of the health status of people with Parkinson’s disease and their spouses

    F. Noubary, S.D. Gunnery, E.M. Naumova, M. Saint-Hilaire, C.A. Thomas, L. Tickle-Degnen (Boston, MA, USA)

    Objective: To demonstrate an innovative visualization method for measuring the interdependence of the health status of people with Parkinson's disease (PD) and their spouses over…
  • 2016 International Congress

    Prescribed gait tests versus continuous monitoring of gait in people with Parkinson’s disease

    C. Curtze, J. McNames, M. El-Gohary, J.G. Nutt, M. Mancini, P. Carlson-Kuhta, F.B. Horak (Portland, OR, USA)

    Objective: To determine if prescribed self-administered gait tests are a valid measure of functional everyday mobility in people with idiopathic Parkinson's disease (PD). Background: Motor…
  • 2016 International Congress

    Testing feasibility and utility of remote data capture technology to assess Parkinson’s disease

    J. Carter, N. Hellmers, A. Hanineva, C. Henchcliffe (New York, NY, USA)

    Objective: To test feasibility and utility of home-based video-recording uploaded from a mobile device app to a cloud-based storage platform, in order to quantitate motor…
  • 2016 International Congress

    Two new cases of a novel ovario-leukodystrophy related to AARS2 mutation from Korea

    H.J. Yang, J.M. Lee, J.H. Kwon, S.T. Lee, H.J. Kim, B. Jeon (Ulsan, Korea)

    Objective: Progressive leukoencephalopathy with primary ovarian failure (LKENP; OMIM # 615889) is a novel ovario-leukodystophy caused by compound heterozygote mutations in the AARS2 gene of…
  • 2016 International Congress

    Mutational analysis of GNAL gene in isolated dystonia patients from Spain

    P. Gómez-Garre, I. Huertas-Fernández, M.T. Cáceres-Redondo, A. Alonso-Canovas, I. Bernal-Bernal, A. Blanco-Ollero, M. Bonilla-Toribio, J.A. Burguera, M. Carballo, F. Carrillo, M.J. Catalán-Alonso, F. Escamilla-Sevilla, R. Espinosa-Rosso, M.C. Fernández-Moreno, J. García-Caldentey, J.M. García-Moreno, S. Giacometti-Silveira, J. Gutiérrez-García, S. Jesús-Maestre, E. López-Valdés, J.C. Martínez-Castrillo, M.P. Medialdea-Natera, C. Méndez-Lucena, A. Mínguez-Castellanos, M. Moya, J.J. Ochoa-Sepúlveda, T. Ojea, N. Rodríguez, I. Rubio-Agusti, M. Sillero-Sánchez, J. del Val, L. Vargas-González, P. Mir (Seville, Spain)

    Objective: To study the frequency and spectrum of GNAL genetic variations in a large population of isolated dystonia (DT) patients from Spain. Background: GNAL encodes…
  • 2016 International Congress

    Roles of combined functional catechol-o-methyltransferase genotypes in Chinese Parkinson’s disease: A cross-sectional survey

    Y. Qian, X. Yang, S. Xu, J. Liu, Q. Xiao (Shanghai, People's Republic of China)

    Objective: To investigate the association of the most common functional catechol-O-methyltransferase (COMT) gene haplotypes with risk to develop of Parkinson's disease (PD) and the association…
  • « Previous Page
  • 1
  • …
  • 183
  • 184
  • 185
  • 186
  • 187
  • …
  • 207
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley